Extracellular vesicles of pathogenic fungi: biogenesis, immune regulation and therapeutic potential.
- 1Department of Clinical Laboratory, The Second Hospital of Jilin University, Changchun, China.
- 2Good Clinical Practice (GCP) Office, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
- 3Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, China.
Abstract
Extracellular vesicles (EVs) encapsulate a variety of biologically active molecules, such as proteins, lipids, and nucleic acids, and have been recognized as crucial mediators of intercellular communication. The production of EVs has been observed across numerous fungal species. Upon infection by pathogenic microorganisms, EVs contribute to the regulation of various pathophysiological processes and are instrumental in the activation and modulation of host immune responses through the transport of molecules derived from either the pathogen or the host. Nonetheless, several aspects of fungal EV biology remain inadequately understood, particularly regarding their potential applications as biomarkers for clinical diagnosis and as therapeutic targets for fungal infections. This review consolidates the current understanding of fungal EVs, with a particular focus on their biogenesis and secretion, their roles in host-pathogen interactions, and their potential applications as diagnostic and therapeutic tools for fungal infections. This includes their translational potential as diagnostic biomarkers, antifungal drug delivery systems, and fungal vaccine candidates. Additionally, the review explores emerging technologies such as single-vesicle analysis, multi-omics profiling, EV engineering, and synthetic and semisynthetic vesicular systems. The discussion aims to offer new perspectives and directions for the early prevention and treatment of microbial infections, while establishing a foundation for further fundamental research and the clinical translation of EV-based strategies.
Related
- The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
- Insights into extracellular vesicles: From biogenesis and tumor immune modulation to their clinical potential in immunotherapy.
- The Tendon Extracellular Matrix: From Hierarchical Architecture to Systemic Regulation and Therapeutic Translation
- Extracellular vesicles in the immune regulation of hematological malignancies: mechanisms, prognostic significance, and therapeutic opportunities
- Stem Cell-Derived Extracellular Vesicles in Bladder Cancer: Diagnostic Potential and Therapeutic Challenges.
BibTeX
@article{wu2026extracellular,
title = {{Extracellular vesicles of pathogenic fungi: biogenesis, immune regulation and therapeutic potential.}},
author = {Jing Wu and Xinyao Qu and Longfei Yang and Xuerui Wang and Li Xu and Yu Zhang},
journal = {Frontiers in cellular and infection microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1922490},
url = {https://europepmc.org/article/MED/43011347},
note = {CC BY},
}
RIS
TY - JOUR
TI - Extracellular vesicles of pathogenic fungi: biogenesis, immune regulation and therapeutic potential.
AU - Jing Wu
AU - Xinyao Qu
AU - Longfei Yang
AU - Xuerui Wang
AU - Li Xu
AU - Yu Zhang
PY - 2026
DA - 2026/10/27
JO - Frontiers in cellular and infection microbiology
DO - 10.3389/fcimb.2026.1922490
UR - https://europepmc.org/article/MED/43011347
AB - Extracellular vesicles (EVs) encapsulate a variety of biologically active molecules, such as proteins, lipids, and nucleic acids, and have been recognized as crucial mediators of intercellular communication. The production of EVs has been observed across numerous fungal species. Upon infection by pathogenic microorganisms, EVs contribute to the regulation of various pathophysiological processes and are instrumental in the activation and modulation of host immune responses through the transport of molecules derived from either the pathogen or the host. Nonetheless, several aspects of fungal EV biology remain inadequately understood, particularly regarding their potential applications as biomarkers for clinical diagnosis and as therapeutic targets for fungal infections. This review consolidates the current understanding of fungal EVs, with a particular focus on their biogenesis and secretion, their roles in host-pathogen interactions, and their potential applications as diagnostic and therapeutic tools for fungal infections. This includes their translational potential as diagnostic biomarkers, antifungal drug delivery systems, and fungal vaccine candidates. Additionally, the review explores emerging technologies such as single-vesicle analysis, multi-omics profiling, EV engineering, and synthetic and semisynthetic vesicular systems. The discussion aims to offer new perspectives and directions for the early prevention and treatment of microbial infections, while establishing a foundation for further fundamental research and the clinical translation of EV-based strategies.
SN - 2235-2988
ER -